Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
Abinit Saha, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang‐Soo Lee, Chiranjib Chakraborty
Topics & Concepts
TocilizumabCytokine stormCytokine release syndromeCytokineMedicineInterleukin 6ImmunologyCytokine receptorMAPK/ERK pathwayReceptorMonoclonal antibodyInterleukin-6 receptorCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseAntibodySignal transductionBiologyCell biologyRheumatoid arthritisInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesAutoimmune and Inflammatory Disorders Research